LAVA Therapeutics NV
Clinical-stage immuno-oncology company developing therapies via its Gammabody® platform.
LVTX | US
Overview
Corporate Details
- ISIN(s):
- NL0015000AG6
- LEI:
- Country:
- United States of America
- Address:
- YALELAAN 62, 0 UTRECHT
- Sector:
- Manufacturing
Description
LAVA Therapeutics NV is a clinical-stage immuno-oncology company that develops cancer therapies through its proprietary Gammabody® platform. This platform generates bispecific antibodies designed to engage and activate Vγ9Vδ2 (Vgamma9 Vdelta2) T cells, a unique and abundant subset of immune effector cells. The therapeutic approach aims to direct these T cells to tumors, leading to the selective killing of cancer cells and the stimulation of a broader, durable anti-tumor immune response. The company's focus is on creating treatments that complement natural tumor recognition and have the potential to enhance patient survival across various malignancies.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all LAVA Therapeutics NV filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for LAVA Therapeutics NV
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for LAVA Therapeutics NV via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
/other/Diamyd_Medical_AB_publ-logo.png){kind=logo}